Methods and compositions for treating edema refractory to oral diuretics
US11260038B1 · kind B1 · utility
1Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 11, 2021 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.